We show that SV40 infection of human mesothelial cells directly causes overexpression of Notch-1, a key cell regulatory gene. Notch-1 induction is achieved at the transcriptional level and requires both the SV40 large Tantigen and the small t-antigen. Notch-1 upregulation is maintained in SV40-transformed human mesothelial clones and in SV40-positive mesotheliomas and derived cell lines. Activation of Notch-1 promotes cell cycle progression and it is required for the growth of SV40-transformed mesothelial cells. Our finding is relevant to the process of SV40-mediated human cell transformation, an effect that cannot be accounted for solely by SV40-Tag inhibition of Rb and p53.
Introduction
Human mesothelial cells (HM) line the surface of the pleural, pericardial and peritoneal cavities, and give rise to mesotheliomas. Mesotheliomas are very aggressive human cancers that have been historically linked to asbestos exposure (Mossman et al., 1990; Robledo and Mossman, 1999; Carbone et al., 2002) , and more recently to SV40 (Butel and Lednicky, 1999; Carbone et al., 2002; Klein et al., 2002; Mossman and Gruenert, 2002; Powers and Carbone, 2002) . Since 1950, in the USA mesotheliomas have been increasing from almost none to about 2500/y. The possibility that SV40 and asbestos are cocarcinogens has been raised (Bocchetta et al., 2000; Klein, 2000; Testa et al., 2001; Mossman and Gruenert, 2002) . Recent data reviewed at a consensus meeting have conclusively associated SV40 with mesothelioma (Klein et al., 2002) . Pathogenesis is supported by numerous reports indicating that SV40 is specifically present in mesothelioma cells and that it is absent in nearby stromal cells (Shivapurkar et al., 1999; and reviewed in Klein et al., 2002) . In mesothelioma cells SV40 inactivates several tumor suppressors, and at the same time promotes telomerase activity and the release of growth factors necessary for tumor growth Powers and Carbone, in press ). However, many molecular mechanisms that follow SV40 infection of HM, which then cause malignant transformation remain unknown (Klein et al., 2002) .
SV40 shares with all DNA tumor viruses the capacity to inactivate cellular p53 and Rb-family proteins (Ali and De Caprio, 2001; Testa and Giordano, 2001 ). Contrary to other DNA tumor viruses, poliomaviruses (including SV40) use one single protein (the large tumor antigen, or Tag) to inactivate both p53 and pRb-family proteins. Tag also regulates SV40 DNA replication and transcription, and interacts with a number of host proteins (Ali and De Caprio, 2001; Testa and Giordano, 2001) .
Following infection of human fibroblasts, SV40 replicates and rapidly lyses the infected cells; therefore, human fibroblasts are rarely transformed or immortalized (Rizzo et al., 2001) . To circumvent the problem of cell lysis, the biological effects of SV40 infection of human cells have been studied using nonreplicating (oriminus) plasmids. These studies revealed that the expression of Tag was insufficient to cause human cell transformation, unless the SV40 small t-antigen (tag) was coexpressed in the same cells (Rundell and Parakati, 2001) . The SV40 tag binds and inhibits Protein Phosphatase 2A (PP2A), a protein involved in the dephosphorylation of many protein substrates, including components of the MAP-kinase (MAPK) pathway. Through inhibition of PP2A, tag may alter the activity of several phosphoproteins, and thus, it may indirectly reinforce mitogenic stimuli acting through MAPK signaling and induce AP-1 activity (Frost et al., 1994; Rundell and Parakati, 2001; Testa et al., 2001) .
The possible relevance of SV40 infection experiments of human cells to human mesothelioma was unclear until we discovered that in contrast to other human cell types, HM were resistant to SV40 cell lysis (Bocchetta et al., 2000; Klein, 2000) . This finding was recently confirmed and expanded by two independent research teams (Cacciotti et al., 2001; Yu et al., 2001) . The prolonged expression of SV40 Tag and tag in the absence of cell lysis caused a very high rate of HM transformation and immortalization (Bocchetta et al., 2000) . Plasmids containing only Tag sequences were unable to transform and/or immortalize HM (Bocchetta et al., 2000; Yu et al., 2001) , as previously observed in human fibroblasts (Rundell and Parakati, 2001) . Thus, in addition to Tag-mediated carcinogenesis, which in HM include the inactivation of cellular p53 Wiman and Klein, 1997) and pRb-family proteins (De Luca et al., 1997) , the activation of the insulin-like growth factor and its receptor (Pass et al., 1996) , and possibly the activation of the Ras and Raf pathways described in other SV40 transformation models (Grammatikakis et al., 2001) , other SV40 functions cause HM transformation and immortalization (Klein et al., 2002) . We hypothesized that, given the unprecedented capacity of SV40 to induce both HM transformation and HM immortalization soon after infection in cell culture (Bocchetta et al., 2000; Klein, 2000) , SV40 must have influenced a set of pathways regulating HM cell fate. Indeed, we found that HM immortalization appears to be achieved by direct induction of telomerase activity by SV40 soon after infection (Foddis et al., 2002) ; but this effect does not cause cellular transformation (Yu et al., 2001; Foddis et al., 2002) . Therefore, the other SV40-mediated cellular effects that cause HM transformation remained unknown. Since Notch-1 signaling has been recently implicated in HPV transformation and in HPVmediated oncogenicity (Rangarajan et al., 2001b) , we investigated the putative interaction between SV40 and the highly pleiotropic Notch signaling pathway.
LIN-12/Notch proteins are evolutionary conserved transmembrane receptors regulating critical cell fate decision during the early development and postnatal life of metazoans, from C. elegans to humans (ArtavanisTsakonas et al., 1999; Miele and Osborne, 1999 . Deregulated expression of Notch receptors has been detected in several human malignancies Jang et al., 2000) . Constitutively active Notch mutants have transforming activities in cultured cells (Capobianco et al., 1997) , and in animal models (Jang et al., 2000) . These data suggest that deregulated or aberrant expression of Notch proteins in differentiated cells are associated with the transformed phenotype. Here, we limited our study to the putative interaction between SV40 and Notch-1, since Notch-1 has been clearly implicated in human cell transformation and in cervical carcinoma, a human cancer strongly associated with HPV infection (Rangarajan et al., 2001b) . Therefore, we performed experiments to address the hypothesis that SV40 induces Notch-1 in HM and in mesotheliomas, to elucidate the viral mechanisms of this putative effect, and finally to verify that Notch-1 activation is biologically relevant in HM.
Results
Notch-1 is overexpressed in SV40-transformed HM, in SV40 positive MM cell lines, and in SV40-positive mesothelioma biopsies
We have previously demonstrated that infection of primary HM with SV40 results in an unusually high rate of cell transformation and immortalization (Bocchetta et al., 2000; Foddis et al., 2002) . Foci arising from SV40-infected HM can be cultured and grow as clones indefinitely. We measured Notch-1 expression in 5 of these clones (at different passages) and in two cell lines obtained from SV40-positive mesothelioma by Western blot analysis. Compared to HM, all cell lines showed a marked overexpression of the Notch-1 gene product. This increased expression was detected either by using an antibody directed against the intracellular (Figure 1a ) or the extracellular portion of the Notch-1 protein ( Figure 1b) . The increased expression of Notch-1 was paralleled by an increase of two of its three Notch ligands Jagged and Jagged2 (Figure 1c (Carbone et al., 1994; Pass et al., 1998) revealed that Notch-1 was expressed only in the SV40 Tag-positive mesotheliomas ( Figure 2 ). Nearby stromal cells were negative for both Tag and Notch-1 ( Figure 2 ). Together, these data suggested that Notch-1 induction was caused by SV40 and that had biological relevance.
To establish whether Notch-1 induction was because of transcriptional activation of the Notch-1 gene, RNAse protection analyses were performed using two different probes, probe 1 complementary to positions 5330-5610 ( Figure 3a were not significantly higher than uninfected HM. Thus, clone 1 achieves upregulation of Notch-1 through mechanisms other than transcriptional activation. Post-transcriptional upregulation of Notch-1 has been observed in other models of transformation (Weijeen et al., 2002) . In most SV40-positive HM, Notch-1 upregulation was paralleled by increased Notch-1 mRNA amounts, and by increased transcription of the Notch-1 gene. These data indicate that SV40-transformed HM and SV40-positive mesothelioma cell lines upregulate full-length Notch-1 protein, because both the intracellular and the extracellular portions of Notch-1 are overexpressed. This situation is different from that of acute lymphoblastic leukemia in which intracellular, truncated forms of Notch-1 are overexpressed (Jang et al., 2000) .
SV40 directly induces Notch-1 upregulation in early infected cells
We next investigated whether Notch-1 upregulation was directly linked to SV40, as opposed to a secondary Note that T7 transcription produces two bands, the lower one most likely representing a pretermination product. (c) Ethidium bromide staining of a 1% agarose-formaldehyde gel to verify equal loading of total RNA from each of the samples shown in (a) and (b). Lanes: 1, probe; 2 and 3, digestion conducted in the absence of total RNA; 4, HM4 (uninfected control); 5, HM5 (uninfected control); 6, clone 1 at psg. 30; 7, clone 4 at psg. 30; 8, clone 12 at psg. 11; 9, clone 12 at psg. 30; 10, clone 6 at psg. 30; 11, clone B5 at psg. 20; 12, mesothelioma cell line ME99; 13, mesothelioma cell line ME2. 8, (clone 12) was not loaded in b because of low amounts of RNA. Differences in Notch-1 mRNA expression levels at different passages of clone 12 may be related to experimental variability consequence of cell transformation. We infected primary HM with SV40 (strain 776, which contains two 72 bp repeats in the enhancer region, a situation most frequently found in mesothelioma; (Pass et al., 1998; Jasani et al., 2001) . At 72 h after infection, Notch-1 protein and mRNA levels were measured by Western (Figure 5a ), RNAse A protection (Figure 5b, c) , and nuclear run-on assay (Figure 4a, b, lanes 2) . Protein analyses demonstrated a marked increase of the Notch-1 protein early after infection. Overexpression of both the unprocessed Notch-1 transmembrane polypeptide (uppermost arrow in Figures 1a, 5a) , and its proteolytic cleavage products, which represent active forms of Notch, or N IC (lowermost arrows in Figures 1a, 5a ) was observed. The same results were obtained in two primary fibroblasts cell cultures (Figure 5a , lanes 9-12) early after SV40 infection. This suggests that Notch-1 induction is a general phenomenon that immediately follows SV40 infection of human cells.
We also found that in early SV40-infected HM, increased Notch-1 protein amounts were paralleled by overexpression of the Notch-1 mRNA (Figure 5b ), and by increased Notch-1 transcription ( Figure 4 , lanes 2). We confirmed Notch-1 induction in our cell system by immunohistochemistry. Early SV40-infected HM accumulated diffuse cytoplasmic Notch-1, while SV40-transformed HM clones accumulated perinuclear Notch-1 protein (not shown). Taken together, these data indicate that SV40 infection directly induces upregulation of Notch-1 through transcriptional activation.
SV40 early region is responsible for Notch-1 induction
We next determined what region of the SV40 genome is sufficient for Notch-1 induction. To assess this, we performed transfection experiments in primary HM. We cloned the complete SV40 early and late regions under the control of a CMV promoter (no SV40 regulatory region sequences were included, see Methods). We chose pGreenLantern2 as the cloning vector in order to obtain recombinant plasmids encoding bi-cystronic mRNAs, comprising either the SV40 early or late region, and, downstream from these region, an open reading frame for green fluorescent protein (GFP). GFP was efficiently translated from these mRNAs, thus allowing us to score the fraction of transfected cells directly by green fluorescence. HM were electroporated with different plasmids, then 3 days after transfections cells were scored for GFP expression and harvested (on average we obtained 25% of positive cells in these transfections). Notch-1 expression in each sample was then assayed by Western blot analysis. To confirm production in transfected cells of SV40 proteins, all samples were tested in parallel by Western blot analysis for Tag or VP-1 expression. The results showed that only cells transfected with the SV40 early region (both alone and in cotransfection with the late region) had strong induction of the Notch-1 protein. HM transfected with the SV40 late region only, as well as cells that received the empty plasmid (control) displayed Notch-1 amounts similar to those of untransfected HM (Figure 6a ). No Notch-1 induction was detected when we used SV40-origin of replication negative plasmids containing only the SV40 regulatory region (Porras et al., 1996) . This suggests that the expression levels of the SV40 early genes play a role in Notch-1 induction in HM.
SV40 tag is necessary for Notch-1 induction. Its functions are exerted through the ERK pathway.
The results showed in Figure 6a indicated that the SV40 early region induces Notch-1. To study which one of the early region gene products (Tag or tag) caused Notch-1 induction, we infected HM with either 'wild-type' (wt) SV40 776, or the SV40 deletion mutant (dl) 884, that does not produce tag because it contains a 247 bp deletion of tag: from 4502 to 4748 deleted (Matthews et al., 1987) . The results showed that, contrary to wt776, dl884 was unable to induce Notch-1 after infection (Figure 6b, lanes 6-9) . This finding suggested that tag was required for Notch-1 induction. Expression of Tag was tested in all infections by immunohistochemistry, and the results were similar between the two SV40 strains (not shown).
The best-known function of tag is related to the binding and consequent inhibition of PP2A, which in turn causes increased phosphorylation of the ERKs cascade components Rundell and Parakati, 2001 ). Thus, we tested whether the two SV40 strains elicited differences in phosphorylation of ERK in HM after infection in vitro. This was studied by Western blot analysis of cell extracts obtained 72 h after infection of HM with either wt776 or dl884, with an antibody specific for phosphorylated (activated) ERK. The results indicated that wt SV40 induced ERK phosphorylation in both early infected HM and in transformed HM clones (Figure 6c ). On the other hand, SV40 dl884 did not induce phosphorylation of ERK in HM after infection (Figure 6d ). Lanes: 1, HM4 (uninfected control); 2, HM4 72 h after SV40 infection; 3, HM4 7 days after SV40 infection; 4, HM4 30 days after SV40 infection; 5, HM5; 6, HM5 72 h after SV40 infection; 7, HM5 7 days after SV40 infection; 8, HM5 30 days after SV40 infection; 9, lung fibroblasts; 10, lung fibroblasts 72 h after SV40 infection; 11, breast fibroblasts; 12, breast fibroblasts 72 h after SV40 infection. (b) RNAse A protection experiment. (c) Denaturing agarose gel in which the same amount of total RNA from each sample in b was loaded. Lanes: 1, probe 2; 2, digestion in the absence of total RNA; 3, HM4 (uninfected control); 4, HM4 72 h after SV40 infection; 5, HM4 7 days after SV40 infection SV40, Notch-1 and mesothelioma M Bocchetta et al Next, we determined whether the lack of Notch-1 induction after infection with SV40 dl884 was related to the inability of this mutant to induce ERK phosphorylation in HM. To address this hypothesis, we infected HM with wt776 in the presence of the MAP-K inhibitor 2 0 -Amino-3 0 -methoxyflavone, which prevents the activation and the phosphorylation of MAP-K in vitro and in vivo (Alessi et al., 1995) . Exposure of HM to 2 0 -amino-3 0 -methoxyflavone did not influence basal Notch-1 expression in these cells (Figure 6b, lanes 2-5) . We found that 2 0 -amino-3 0 -methoxyflavone suppressed SV40 induction of Notch-1 caused by wt776 SV40 infection in a dose-dependent fashion (Figure 6b , lanes 10-13). Finally, to study whether the SV40 tag was necessary and sufficient for Notch-1 induction, we cloned a Tag-negative, tag-positive mutant of the SV40 early region into pGreenLantern2. We detected no induction of Notch-1 protein in HM after expression of tag alone (not shown).
These results indicate that tag is necessary but not sufficient for Notch-1 induction in HM. The SV40 tag appears to affect Notch-1 expression through interaction (presumably indirectly mediated by PP2A) with the ERK signaling pathway. This effect requires the coexpression of Tag, thus suggesting that the two oncoproteins cooperate in Notch-1 induction.
Notch-1 is required for the growth of SV40-transformed mesothelial cells
Notch-1 signaling effects have been described to be celltype-dependent. For example, activation of Notch-1 causes inhibition of differentiation and enhanced progression through G1 in human hematopoietic progenitor cells (Carlesso et al., 1999) , but growth arrest and differentiation in keratinocytes (Rangarajan et al., 2001a) . To test Notch effects in HM, we transfected HM with a plasmid coding for a constitutively active form of Notch-1 (pICN). FACS results indicated that about two times more cells were in G2/M in the pICN-transfected group compared to cells transfected with the empty plasmid (not shown). To verify the biological relevance of this finding to the SV0-HM transformation process, we treated SV40-transformed and infected HM with the gamma-secretase inhibitor Boc-k (Dnp)IL-epoxide (ILX) (McLendon et al., 2000) . ILX treatment inhibited the cleavage of the intracellular portion of Notch-1 (Figure 7, top) , which is required for Notch-1 activity and caused complete arrest of cell growth. FACS analyses revealed that treated cells were arrested in G2/M (Figure 7 , bottom). Therefore, activation of Notch-1 signaling in SV40-transformed HM is required for cell growth. However, Notch-1 activation alone is not sufficient for HM transformation, because no foci developed out of more than 10 7 cells transfected with constitutively active Notch-1 in three separate experiments using two different primary HM (cells were followed for 2 months after transfection).
Discussion
We found that SV40 infection causes Notch-1 induction in early infected cells, and that this induction is achieved by transcriptional activation of Notch-1. Tag and tag are both required for Notch-1 induction, and tag appears to exert its activity through the ERK signaling pathway. Transfections indicated that gene dosage and/ or levels of expression of the SV40 tumor antigens play a critical role in Notch-1 activation. Nonreplicating plasmids encoding the SV40 tumor antigens under the control of the SV40 promoter did not induce Notch-1. On the other hand, infections (in which there is replication of the SV40 genome, and therefore, increased gene dosage) and transfection with plasmids in which transcription of the SV40 tumor antigens was controlled by a strong promoter (CMV) caused Notch-1 induction. Immunostaining showed diffuse cytoplasmic Notch-1 expression in HM early after SV40 infection, and sharply perinuclear localization of Notch-1 in SV40-transformed HM clones, and in mesotheliomas Wu et al., 2001) . Recent evidence suggests that active Notch-1 may induce nuclear transfer of its target CBF-1 from the cytoplasm, rather than interacting with it in the nucleus (Zhou and Hayward, 2001 ). This could explain reports indicating that cytoplasmic and perinuclear Notch-1 localization is related to Notch activation in some cell systems (Artavanis-Tsakonas et al., 1999).
SV40 can be expected to induce a number of molecular changes following HM infection; therefore, it is critical to distinguish the effects that are biologically relevant to the malignant phenotype to those that are not. Notch-1 was overexpressed in SV40-transformed HM clones, in SV40-positive mesothelioma biopsies, and in cell lines derived from SV40-positive mesotheliomas. Therefore, there is a strong link between SV40 infection and Notch-1 expression in HM and mesotheliomas and it appears that the expression of Notch-1 is required for malignant growth. This hypothesis is supported by the observation that treatment of SV40-transformed HM and SV40-positive mesothelioma cell lines with a gamma secretase inhibitor, which interfered with Notch-1 cleavage and activation, caused cell growth arrest. However, the apparent lack of Notch-1 expression in SV40-negative mesotheliomas suggests that Notch-1 may not always be required for mesothelioma growth. It is possible that some molecular changes, such as Notch-1 expression, are unique to SV40-positive mesotheliomas. Accordingly, RASSF1A (Toyooka et al., 2001) , and met (Cacciotti et al., 2001) seem specifically altered in SV40-positive mesotheliomas. The hypothesis that unique molecular events characterize SV40-positive mesotheliomas has clinical implications, because it may be possible to develop therapeutic strategies that target these mechanisms (Imperiale et al., 2001; Schrump and Waheed, 2001 ). Notch-1 gene appears as an attractive target for molecular chemotherapy (Jang et al., 2000) , and mesotheliomas may be ideal candidates of novel therapies that target Notch-1 expression because of their almost complete lack of response to current therapies , and because of their location in a closed space (the pleural cavity).
Constitutively active Notch-1 independently increased the fraction of primary HM in the G2/M phase of the cell cycle and expression of active Notch-1 was required for HM proliferation. At the same time, by increasing the fraction of cells in G2/M, when cells are most susceptible to mutagenic events caused by carcinogens such as asbestos (Mossman et al., 1990; Robledo and Mossman, 1999; Carbone et al., 2002) , Notch-1 may indirectly favor HM transformation. This hypothesis would be consistent with the suggested role of Notch-1 in HPV-dependent transformation of cervical epithelial cells (Rangarajan et al., 2001b) . Similar considerations have been made for EBV-induced transformation where the viral protein EBNA2 may mimic Notch-1 to activate CBF-1 (Hsieh et al., 1997) . However, in our system, SV40 directly upregulates Notch-1, and this direct effect by a DNA tumor virus has not been previously demonstrated.
In summary, Notch-1 induction is a novel activity of SV40 required for the maintenance of the transformed phenotype of HM. We defined the viral mechanisms of Notch-1 activation. Notch-1 regulates multiple cellular pathways: our finding will allow us to study these pathways to obtain a more complete understanding of the mechanisms that contribute to SV40 transformation of HM, an effect that could not be accounted for only by the transforming activity of Tag (Wiman and Klein, 1997; Klein et al., 2002) . It is possible that similar to p53 and Rb inactivation, cellular genes that regulate multiple pathways, Notch-1 induction is an activity required for human cell transformation by other DNA tumor viruses. Experiments are in progress in our laboratory to test whether JC, a human polyomavirus present in brain tumors, sometimes together with SV40 (Krynska et al., 1999) also induces Notch-1 activity.
Materials and Methods
Cell culture, infections, and treatment conditions HM were cultured from pleural fluids obtained from noncancerous donors as previously described (Bocchetta et al., 2000) . Immunohistochemical studies were conducted to verify that the cells were mesothelial cells (HM are positive for calretinin, WT-1 and pankeratin, and negative for CEA, Leu-M-1, and B72.3). We used four primary HM (HM4, HM5, HM6, and HM7) obtained from different donors, all four had a similar biological behavior and the results of the experiments were not influenced by the type of HM used. All four HM cultures were SV40-free as determined by immunostaining and PCR analyses. SV40-transformed HM clones were previously described (Bocchetta et al., 2000) . Cell lines, ME2 and ME99, were obtained from SV40 positive MM and were a generous gift from Luciano Mutti. Both SV40-transformed HM clones and MM cell lines were grown in DMEM supplemented with 5% fetal bovine serum (FBS). Human primary diploid fibroblasts WI38 and CCD1069Sk (named BF in the text) were obtained from ATCC, and cultured in DMEM supplemented with 10% FBS. Infection experiments were performed as follows: 18 h before infection, confluent cultures were expanded 1 : 2. Then SV40 was added at a multiplicity of infection (MOI) of 30. (Two viruses were used: SV40 776, also known as 'wild-type SV40 or nonarchetypal SV40', and SV40 dl884, which contains a mutation in the early region intron that impairs the synthesis of tag (Matthews et al., 1987) . Cells were dissociated 48 h after infection using trypsin/ EDTA, and aliquoted in tissue culture flasks and in glass-slide chambers (the latter for immunostaining). Uninfected cells (controls) were handled accordingly. The following day, 72 h after infection, cells were dissociated with trypsin, washed three times with DMEM supplemented with 10% FBS, then washed once with cold PBS, and harvested in Eppendorf tubes for further analysis. Infections the presence of 2 0 -Amino-3 0 -methoxyflavone (Biomol) were performed in a similar fashion, except that 24 h before harvesting, the tissue culture media of the cells were supplemented with 2 0 -amino-3 0 -methoxyflavone to achieve the final concentrations specified in the figure legends.
Plasmids, transfection, and flow cell cytometry
We used the following plasmids: pw2 and pw2t (ori-plasmid containing, respectively, the SV40 complete early region under the control of the SV40 promoter, and a mutant expressing tag only); both plasmids have been previously described (Porras et al., 1996) and used by us (Bocchetta et al., 2000) . DNA obtained from a PCR amplification of the SV40 early genes region (in which a SacII site was artificially introduced immediately upstream from the Tag initiation codon, and a SalI site was introduced immediately downstream from the Tag stop codon) was ligated into the SacII and SalI sites of GreenLantern2 (Gibco BRL). The recombinant plasmid was sequenced to confirm the absence of eventual PCR-introduced mutations, and named pEARLY. pLATE, consisting of the SV40 late genes region cloned into the SacII and SalI sites of GreenLantern2 was constructed following a strategy similar to that of pEARLY. pSMALLT was obtained after ligation into the SacII and SalI sites of GreenLantern2 of the tag gene obtained from PCR amplification using pw2t as the template. In summary, pEARLY, pLATE, and pSMALLT contained, respectively, the SV40 early genes, late genes, and tag gene under the control of the CMV promoter. Transcription from the CMV promoter gave rise to polycistronic mRNA containing the above genes and, downstream from them, a Green Fluorescent Protein (GFP) open reading frame. The plasmid pICN, expressing a constitutively active, intracellular Notch-1, has been previously described (Aster et al., 2000) .
Transfection experiments were performed as follows: 18 h before transfection cells were expanded 1 : 2. Then, the cells were dissociated by trypsin/EDTA treatment, washed once with DMEM supplemented with 10% FBS to inactivate trypsin, and then washed three times in RPMI medium without FBS. Cells (5 Â 10) in 0.8 ml of RPMI medium were then transfected with 10 mg of endotoxin-free plasmids by electroporation using a Gene Pulser II apparatus (BioRad). On average, the efficiency of transfection of different HMs using this method was 25%, as determined by direct fluorescence for GFP. In transfection experiments in which plasmids did not contain GFP, 10 mg of GreenLantern2 was cotransfected along with the plasmids to assess transfection efficiency. After electroporation, cells were cultured in DMEM supplemented with 20% FBS. FACS analyses were performed 24 h after transfection of either pICN or pCDNA3 (empty plasmid control). DNA content by propidium iodide staining experiments were performed according to a protocol available at http://facs.luhs.org/FACS%20WWW%20Server/Methods/ PI.html. Western blot analyses were performed 48 h after transfection.
Antibodies, immunochemistry, and Western blot experiments
We used the following antibodies: AB-597 mouse monoclonal specific for the SV40 VP1 (a gift from FJ O'Neil; Salt Lake City, UT, USA); mouse monoclonal antibody PAb 419, specific for Tag (Calbiochem); C-20, goat polyclonal antibody specific for the intracellular portion of human Notch-1 (Santa Cruz); rabbit polyclonal antibody specific for the extracellular portion of human Notch-1 (Shelly et al., 1999) ; rabbit polyclonal antibody 442705, specific for human MAP-kinase, phospho-specific (Calbiochem); goat polyclonal antibodies sc-6011, specific for Jagged, sc-8157, specific for Jagged 2, sc-8155, specific for Delta (Santa Cruz Biotech.); polyclonal rabbit antibody Val1744 (Cell Signaling Tech.), specific for activated (cleaved between sites Gly1743 and Val1744) Notch-1. Immunohistochemistry for Tag was performed routinely on SV40-infected cells 72 h after infection to assess efficiency of infection. Immunohistochemistry for Notch-1 was performed using C-20 antibody. Protein lysates, Western blotting, and immunostaining experiments were conducted as described (Bocchetta et al., 2000) . Immunohistochemistry on frozen sections was performed on 12 frozen biopsies from different patients with mesothelioma as described (Carbone et al., 1994) . Notch-1 staining was performed using C-20 antibody diluted 1 : 50, and Tag immunostaining using pAb 419 (Ab-1 Oncogene Science) diluted 1 : 20. Reactions were developed using the ABC-elite kit (Vector), visualized with DAPperoxidase kit (Vector), and examined by light microscopy.
RNAse A protection and nuclear run-on assays We used two riboprobes for our RNAse A protection assays: probes 1 and 2, antisense, respectively, to positions 5330-5610, and to positions 1325-1471 of the human Notch-1 cDNA. Probe 1 was obtained after linearization of plasmid pE(H/ B)280-3Z with BamHI, followed by SP6 in vitro transcription SV40, Notch-1 and mesothelioma M Bocchetta et al
